170 related articles for article (PubMed ID: 38323308)
41. Hypoxia-primed monocytes/macrophages enhance postinfarction myocardial repair.
Zhu Y; Yang W; Wang H; Tang F; Zhu Y; Zhu Q; Ma R; Jian Z; Xiao Y
Theranostics; 2022; 12(1):307-323. PubMed ID: 34987647
[No Abstract] [Full Text] [Related]
42. Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice.
Kain V; Ingle KA; Rajasekaran NS; Halade GV
Theranostics; 2021; 11(6):2742-2754. PubMed ID: 33456570
[No Abstract] [Full Text] [Related]
43. Bone marrow-derived Ly6C
Yang Q; Wang Y; Pei G; Deng X; Jiang H; Wu J; Zhou C; Guo Y; Yao Y; Zeng R; Xu G
Cell Death Dis; 2019 Mar; 10(4):291. PubMed ID: 30926787
[TBL] [Abstract][Full Text] [Related]
44. TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization.
Hu X; Xu Y; Zhang Z; Tang Z; Zhang J; Luo Y; Deng W; Dong Z; Zhao Y; Na N
Front Immunol; 2021; 12():637335. PubMed ID: 33767704
[TBL] [Abstract][Full Text] [Related]
45. Curcumin Ameliorates Cardiac Fibrosis by Regulating Macrophage-Fibroblast Crosstalk
Zhao J; Chen Y; Chen Q; Hong T; Zhong Z; He J; Ni C
Front Pharmacol; 2021; 12():784041. PubMed ID: 35115932
[No Abstract] [Full Text] [Related]
46. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
47. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
Karlmark KR; Weiskirchen R; Zimmermann HW; Gassler N; Ginhoux F; Weber C; Merad M; Luedde T; Trautwein C; Tacke F
Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540
[TBL] [Abstract][Full Text] [Related]
48. Ly6C
Kimball A; Schaller M; Joshi A; Davis FM; denDekker A; Boniakowski A; Bermick J; Obi A; Moore B; Henke PK; Kunkel SL; Gallagher KA
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1102-1114. PubMed ID: 29496661
[TBL] [Abstract][Full Text] [Related]
49. Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis.
Baci D; Bosi A; Parisi L; Buono G; Mortara L; Ambrosio G; Bruno A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998408
[TBL] [Abstract][Full Text] [Related]
50. Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.
Wang YY; Jiang H; Pan J; Huang XR; Wang YC; Huang HF; To KF; Nikolic-Paterson DJ; Lan HY; Chen JH
J Am Soc Nephrol; 2017 Jul; 28(7):2053-2067. PubMed ID: 28209809
[TBL] [Abstract][Full Text] [Related]
51. Pivotal role of phospholipase D1 in tumor necrosis factor-α-mediated inflammation and scar formation after myocardial ischemia and reperfusion in mice.
Schönberger T; Jürgens T; Müller J; Armbruster N; Niermann C; Gorressen S; Sommer J; Tian H; di Paolo G; Scheller J; Fischer JW; Gawaz M; Elvers M
Am J Pathol; 2014 Sep; 184(9):2450-64. PubMed ID: 25046692
[TBL] [Abstract][Full Text] [Related]
52. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
[TBL] [Abstract][Full Text] [Related]
53. QiShenYiQi Pills
Zheng QN; Wei XH; Pan CS; Li Q; Liu YY; Fan JY; Han JY
Pharmacol Res; 2019 Aug; 146():104272. PubMed ID: 31085230
[TBL] [Abstract][Full Text] [Related]
54. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Frangogiannis NG; Dewald O; Xia Y; Ren G; Haudek S; Leucker T; Kraemer D; Taffet G; Rollins BJ; Entman ML
Circulation; 2007 Feb; 115(5):584-92. PubMed ID: 17283277
[TBL] [Abstract][Full Text] [Related]
55. Extracellular vesicles derived from Krüppel-Like Factor 2-overexpressing endothelial cells attenuate myocardial ischemia-reperfusion injury by preventing Ly6C
Qiao S; Zhang W; Yin Y; Wei Z; Chen F; Zhao J; Sun X; Mu D; Xie J; Xu B
Theranostics; 2020; 10(25):11562-11579. PubMed ID: 33052233
[No Abstract] [Full Text] [Related]
56. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
Marinković G; Grauen Larsen H; Yndigegn T; Szabo IA; Mares RG; de Camp L; Weiland M; Tomas L; Goncalves I; Nilsson J; Jovinge S; Schiopu A
Eur Heart J; 2019 Aug; 40(32):2713-2723. PubMed ID: 31292614
[TBL] [Abstract][Full Text] [Related]
57. Conditioned medium from adipose-derived stem cells attenuates ischemia/reperfusion-induced cardiac injury through the microRNA-221/222/PUMA/ETS-1 pathway.
Lee TL; Lai TC; Lin SR; Lin SW; Chen YC; Pu CM; Lee IT; Tsai JS; Lee CW; Chen YL
Theranostics; 2021; 11(7):3131-3149. PubMed ID: 33537078
[No Abstract] [Full Text] [Related]
58. Cardiac Hyaluronan Synthesis Is Critically Involved in the Cardiac Macrophage Response and Promotes Healing After Ischemia Reperfusion Injury.
Petz A; Grandoch M; Gorski DJ; Abrams M; Piroth M; Schneckmann R; Homann S; Müller J; Hartwig S; Lehr S; Yamaguchi Y; Wight TN; Gorressen S; Ding Z; Kötter S; Krüger M; Heinen A; Kelm M; Gödecke A; Flögel U; Fischer JW
Circ Res; 2019 May; 124(10):1433-1447. PubMed ID: 30916618
[TBL] [Abstract][Full Text] [Related]
59. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction.
Vilahur G; Juan-Babot O; Peña E; Oñate B; Casaní L; Badimon L
J Mol Cell Cardiol; 2011 Mar; 50(3):522-33. PubMed ID: 21219908
[TBL] [Abstract][Full Text] [Related]
60. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.
Mia MM; Cibi DM; Abdul Ghani SAB; Song W; Tee N; Ghosh S; Mao J; Olson EN; Singh MK
PLoS Biol; 2020 Dec; 18(12):e3000941. PubMed ID: 33264286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
